Inhibrx Biosciences, Inc.INBX stock score: 38/100

$74.33 · +7.63% · Scored Nov 19, 2026

Technical
29
Fundamental
40
News
58

The reading

Inhibrx Biosciences (INBX) scores 38 out of 100, which reads bearish, higher than 17% of Healthcare stocks and 18% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 40, technicals 29.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Growth (Annual) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 16 and contrarian oscillators 64 — a split worth reading before trusting the technical total.

News sentiment is neutral at 58; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 37 to 56, and it is down 17 points over the period.

About Inhibrx Biosciences

Inhibrx Biosciences (INBX) is a clinical-stage biotechnology company that develops antibody-based therapies for cancer. It was spun off when Sanofi acquired its predecessor company. Its lead product candidate, ozekibart, also known as INBRX-109, is a multivalent antibody designed to activate death receptor 5, which can trigger cancer cell death. In a randomized, placebo-controlled trial in conventional chondrosarcoma, a bone cancer with no approved systemic therapy, ozekibart extended the time patients lived without their disease progressing, and the company has sought U.S. approval for that use. It is also testing ozekibart with chemotherapy in Ewing sarcoma and colorectal cancer. Its second program, INBRX-106, is an immune-stimulating antibody studied with Keytruda in head and neck cancer. It has no product revenue and funds research through cash, borrowing and stock sales.

Inhibrx competes with larger oncology drug developers such as Merck and Bristol Myers Squibb, along with biotech companies developing treatments for sarcomas and solid tumors. Its edge rests on protein engineering that lets it build antibodies with multiple binding sites to boost activity, and an early position in a rare cancer with few treatment options. Investors who follow INBX stock tend to watch the U.S. regulatory review of ozekibart and plans for its commercial launch. Data from the Ewing sarcoma, colorectal cancer and head and neck studies are closely followed. Cash runway, debt and share dilution are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward INBX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

40

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

36 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical · daily

22

Pulling it up

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • Directional, despite the name: the net 14-day move divided by the total Average True Range over the same days, compared with the stock's own history.

  • Williams %R (7-period) places the close within the last 7 periods' high-low range.

Holding it back

  • Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Simple Moving Average (50-period) is a widely-watched intermediate-term trend gauge.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
58

Technical score by timeframe

ChartScoreWeight
Hourly441
Daily223
Weekly342

Composite score, last 90 days

05010038Aug 22, 2026Nov 19, 2026Aug 22, 2026: 55Aug 23, 2026: 55Aug 24, 2026: 54Aug 25, 2026: 56Aug 26, 2026: 55Aug 27, 2026: 54Aug 28, 2026: 55Aug 29, 2026: 55Aug 30, 2026: 55Aug 31, 2026: 55Sep 1, 2026: 54Sep 2, 2026: 54Sep 3, 2026: 55Sep 4, 2026: 54Sep 5, 2026: 54Sep 6, 2026: 54Sep 7, 2026: 54Sep 8, 2026: 53Sep 9, 2026: 52Sep 10, 2026: 51Sep 11, 2026: 51Sep 12, 2026: 51Sep 13, 2026: 51Sep 14, 2026: 51Sep 15, 2026: 50Sep 16, 2026: 49Sep 17, 2026: 51Sep 18, 2026: 52Sep 19, 2026: 52Sep 20, 2026: 52Sep 21, 2026: 52Sep 22, 2026: 53Sep 23, 2026: 51Sep 24, 2026: 51Sep 25, 2026: 48Sep 26, 2026: 48Sep 27, 2026: 48Sep 28, 2026: 50Sep 29, 2026: 52Sep 30, 2026: 49Oct 1, 2026: 47Oct 2, 2026: 47Oct 3, 2026: 47Oct 4, 2026: 47Oct 5, 2026: 46Oct 6, 2026: 48Oct 7, 2026: 46Oct 8, 2026: 46Oct 9, 2026: 48Oct 10, 2026: 48Oct 11, 2026: 48Oct 12, 2026: 46Oct 13, 2026: 44Oct 14, 2026: 44Oct 15, 2026: 46Oct 16, 2026: 46Oct 17, 2026: 46Oct 18, 2026: 46Oct 19, 2026: 46Oct 20, 2026: 49Oct 21, 2026: 50Oct 22, 2026: 50Oct 23, 2026: 47Oct 24, 2026: 47Oct 25, 2026: 47Oct 26, 2026: 44Oct 27, 2026: 47Oct 28, 2026: 40Oct 29, 2026: 38Oct 30, 2026: 38Oct 31, 2026: 38Nov 1, 2026: 39Nov 2, 2026: 39Nov 3, 2026: 41Nov 4, 2026: 43Nov 5, 2026: 40Nov 6, 2026: 42Nov 7, 2026: 41Nov 8, 2026: 41Nov 10, 2026: 46Nov 11, 2026: 47Nov 12, 2026: 39Nov 13, 2026: 39Nov 14, 2026: 39Nov 15, 2026: 39Nov 16, 2026: 38Nov 17, 2026: 38Nov 18, 2026: 37Nov 19, 2026: 38
Show the daily numbers
DateComposite
Nov 19, 202638
Nov 18, 202637
Nov 17, 202638
Nov 16, 202638
Nov 15, 202639
Nov 14, 202639
Nov 13, 202639
Nov 12, 202639
Nov 11, 202647
Nov 10, 202646
Nov 8, 202641
Nov 7, 202641
Nov 6, 202642
Nov 5, 202640
Nov 4, 202643
Nov 3, 202641
Nov 2, 202639
Nov 1, 202639
Oct 31, 202638
Oct 30, 202638
Oct 29, 202638
Oct 28, 202640
Oct 27, 202647
Oct 26, 202644
Oct 25, 202647
Oct 24, 202647
Oct 23, 202647
Oct 22, 202650
Oct 21, 202650
Oct 20, 202649
Oct 19, 202646
Oct 18, 202646
Oct 17, 202646
Oct 16, 202646
Oct 15, 202646
Oct 14, 202644
Oct 13, 202644
Oct 12, 202646
Oct 11, 202648
Oct 10, 202648
Oct 9, 202648
Oct 8, 202646
Oct 7, 202646
Oct 6, 202648
Oct 5, 202646
Oct 4, 202647
Oct 3, 202647
Oct 2, 202647
Oct 1, 202647
Sep 30, 202649
Sep 29, 202652
Sep 28, 202650
Sep 27, 202648
Sep 26, 202648
Sep 25, 202648
Sep 24, 202651
Sep 23, 202651
Sep 22, 202653
Sep 21, 202652
Sep 20, 202652
Sep 19, 202652
Sep 18, 202652
Sep 17, 202651
Sep 16, 202649
Sep 15, 202650
Sep 14, 202651
Sep 13, 202651
Sep 12, 202651
Sep 11, 202651
Sep 10, 202651
Sep 9, 202652
Sep 8, 202653
Sep 7, 202654
Sep 6, 202654
Sep 5, 202654
Sep 4, 202654
Sep 3, 202655
Sep 2, 202654
Sep 1, 202654
Aug 31, 202655
Aug 30, 202655
Aug 29, 202655
Aug 28, 202655
Aug 27, 202654
Aug 26, 202655
Aug 25, 202656
Aug 24, 202654
Aug 23, 202655
Aug 22, 202655

Key facts

Market cap
$1.1B
Sector
Healthcare
Industry
Biotechnology
Beta
4.04
Risk grade (1–10)
7
Next earnings
Nov 13, 2026

Questions

What is INBX's stock rating today?

INBX scores 38/100 (Bearish) as of Nov 19, 2026: technical 29, fundamental 40, and news sentiment 58, which is shown but not counted. Scores are recomputed every night.

What does Inhibrx Biosciences do?

Inhibrx Biosciences (INBX) is a clinical-stage biotechnology company that develops antibody-based therapies for cancer. It was spun off when Sanofi acquired its predecessor company.

Is INBX stock a buy?

The score is not a buy or sell recommendation. A 38 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the INBX score calculated?

97 weighted scorers feed it today: 36 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 3 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

INBX stock score

HTML

<a href="https://stocksscores.com/stocks/inbx/"><img src="https://stocksscores.com/stocks/inbx/badge.svg" alt="INBX stock score" height="20"></a>

Markdown

[![INBX stock score](https://stocksscores.com/stocks/inbx/badge.svg)](https://stocksscores.com/stocks/inbx/)